Pharmacological characterization of the chronic constriction injury model of neuropathic pain

European Journal of Pharmacology

Volumn 491, Issue 2-3, 2004, Pages 137-148

  De Vry, Jean ^a,b   Kuhl, Ellen ^a   Franken Kunkel, Petra ^a   Eckel, Gisela ^a  

^a CNS Research   (Germany)

^b GRÜNENTHAL GMBH   (Germany)

Author keywords

(Rat); Analgesics; Animal model; Chronic pain; Nociception

Indexed keywords

2 AMINO 4,5,6,7 TETRAHYDROBENZO[B]THIOPHEN 3 YL 4 CHLOROPHENYLMETHANONE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINO 5 (3 BROMOPHENYL) 7 (6 MORPHOLINOPYRIDIN 3 YL)PYRIDO[2,3 D]PYRIMIDINE; 4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; ABT 702; ADENOSINE A1 RECEPTOR; ADENOSINE KINASE INHIBITOR; ALPHA (4 HYDROXYPHENYL) BETA METHYL 4 (PHENYLMETHYL) 1 PIPERIDINE PROPANOL; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; BACLOFEN; CANNABINOID DELTA 9 TETRAHYDROCANNABINOL; CANNABINOID DERIVATIVE; CARBAMAZEPINE; CYCLOOXYGENASE 2 INHIBITOR; DIZOCILPINE; GABAPENTIN; IFENPRODIL; KETAMINE; MORPHINE; MUSCLE RELAXANT AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; ROFECOXIB; T 62; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; HYPERALGESIA; INJURY; MALE; NEUROPATHIC PAIN; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; RELIABILITY; VALIDATION PROCESS; VASOCONSTRICTION;

ANALGESICS; ANIMALS; CONSTRICTION, PATHOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR; SCIATIC NEUROPATHY;

EID: 2342446466     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.03.051     Document Type: Article

References (36)

1. Attal N., Chen Y.L., Kayser V., Guilbaud G. Behavioural evidence that systemic morphine may modulate a phasic pain-related behaviour in a rat model of peripheral mononeuropathy. Pain. 47:1991;65-70
2. Avenet P., Léonardon J., Besner F., Graham D., Depoortere H., Scatton B. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1/NR2A and NR1/NR2B receptors expressed in Xenopus oocytes. Neurosci. Lett. 223:1997;133-136
3. Begon S., Pickering G., Eschalier A., Dubray C. Magnesium and MK-801 have a similar effect in two experimental models of neuropathic pain. Brain Res. 887:2000;436-439
4. Bennett G.J., Xie Y.-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107
5. Boyce S., Wyatt A., Webb J.K., O'Donnell R., Mason G., Rigby M., Sirinathsinghji D., Hill R.G., Rupniak N.M.J. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology. 38:1999;611-623
6. Bridges D., Thompson S.W.N., Rice A.S.C. Mechanisms of neuropathic pain. Br. J. Anaesth. 87:2001;12-26
7. Chan C.-C., Boyce S., Brideau C., Charleson S., Cromlish W., Ethier D., Evans J., Ford-Hutchinson A.W., et al. Rofecoxib [Vioxx, MK-0966; 4-(4′-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J. Pharmacol. Exp. Ther. 290:1999;551-560
8. Decosterd I., Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 87:2000;149-158
9. Dellemijn P. Are opioids effective in relieving neuropathic pain? Pain. 80:1999;453-462
10. De Vry J., Jentzsch K.R. Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine. Behav. Pharmacol. 14:2003;229-235
11. De Vry J., Jentzsch K.R., Kuhl E., Eckel G. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development. Behav. Pharmacol. 15:2004;1-12
12. 2 receptor partial agonist with antihyperalgesic and anti-allodynic effects. J. Pharmacol. Exp. Ther. 2004;. (in press)
13. Erichsen H.K., Blackburn-Munro G. Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain. 98:2002;151-161
14. Gaoini Y., Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86:1964;1646-1647
15. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88
16. Herzberg U., Eliav E., Bennett G.J., Kopin I.J. The analgesic effects of R(+)-WIN 55, 212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci. Lett. 221:1997;157-160
17. Hofmann H.A., De Vry J., Siegling A., Spreyer P., Denzer D. Pharmacological sensitivity and gene expression analysis of the tibial nerve injury model of neuropathic pain. Eur. J. Pharmacol. 470:2003;17-25
18. Hunter J.C., Gogas K.R., Hedley L.R., Jacobson L.O., Kassotakis L., Thompson J., Fontana D.J. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmacol. 324:1997;153-160
19. Johnson M.R., Melvin L.S. The discovery of nonclassical cannabinoid analgesics. Mechoulam R. Cannabinoids as Therapeutic Agents. 1986;121-145 CRC Press, Boca Raton
20. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363
21. Koch B.D., Faurot G.F., McGuirk J.R., Clarke D.E., Hunter J.C. Modulation of mechano-hyperalgesia by clinically effective analgesics in rats with a peripheral mononeuropathy. Analgesia. 2:1996;157-164
22. Koltzenburg M. Painful neuropathies. Curr. Opin. Neurol. 11:1998;515-521
23. Kowaluk E.A., Mikusa J., Wismer C.T., Zhu C.Z., Schweitzer E., Lynch J.J., Lee C.-H., Jiang M., et al. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6- morpholino-pyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: II. In vivo characterization in the rat. J. Pharmacol. Exp. Ther. 295:2000;1165-1174
24. Martin T.J., Eisenach J.C. Pharmacology of opioid and nonopioid analgesics in chronic pain states. J. Pharmacol. Exp. Ther. 299:2001;811-817
25. 3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J. Neurochem. 70:1998;2147-2155
26. Li X., Conklin D., Ma W., Zhu X., Eisenach J.C. Spinal noradrenergic activation mediates allodynia reduction from an allosteric adenosine modulator in a rat model of neuropathic pain. Pain. 97:2002;117-125
27. Lindenlaub T., Sommer C. Partial sciatic nerve transection as a model of neuropathic pain: a qualitative and quantitative neuropathological study. Pain. 89:2000;97-106
28. Pelissier T., Laurido C., Kramer V., Hernández A., Paeile C. Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats. Eur. J. Pharmacol. 477:2003;23-28
29. Pertwee R.G. Cannabinoid receptors and pain. Prog. Neurobiol. 63:2001;569-611
30. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218
31. 1 receptor upregulation in a rat model of chronic neuropathic pain. Eur. J. Pharmacol. 415:2001;R5-R7
32. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 83:1999;389-400
33. Smith G.D., Harrison S.M., Birch P.J., Elliott P.J., Malcangio M., Bowery N.G. Increased sensitivity to the antinociceptive activity of ±baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia. Neuropharmacology. 33:1994;1103-1108
34. Wong E.H.F., Kemp J.A., Priestly T., Knight A.R., Woodruff G.N., Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. U. S. A. 83:1986;7104-7108
35. Xiao W.-H., Bennett G.J. Gabapentin has an antinociceptive effect mediated via a spinal site of action in a rat model of painful peripheral neuropathy. Analgesia. 2:1996;267-273
36. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110